Syngenta has submitted a legal challenge to the European Commission’s decision to suspend the use of thiamethoxam on bee attractive crops. The Commission took the decision on the basis of a flawed process, an inaccurate and incomplete assessment by the European Food Safety Authority and without the full support of EU Member States.
Syngenta Chief Operating Officer, John Atkin, said: “We would prefer not to take legal action but have no other choice given our firm belief that the Commission wrongly linked thiamethoxam to the decline in bee health. In suspending the product, it breached EU pesticide legislation and incorrectly applied the precautionary principle.
“Since the EU suspension of thiamethoxam was announced, farmers and farmer organizations have expressed great concern that an extremely effective, low dose product will not be available to them and will have to be replaced by much less sustainable alternatives. Modern products like thiamethoxam are essential to address the challenge of increasing European food production and reducing the reliance on imports.”
Syngenta called on all stakeholders to concentrate on practical solutions to bee health, which most experts agree is damaged by disease, viruses and the loss of habitat and nutrition. The company confirmed its commitment to support the expansion of Operation Pollinator across Europe and the Bee Health Action Plan, which was published in April 2013.
For more information on Syngenta’s contribution to bee health visit: www.operationpollinator.com
Syngenta is one of the world's leading companies with more than 27,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.